Brazil, which has the third-largest jail people worldwide, is on the cusp of a major change in its pharmaceutical plan. The government’s Supreme Court justices voted on June 25 to enable people to legally possess “personal” quantities of hemp for use. This decision, much deliberated since 2015, signals a possible shift toward decriminalizing hemp, despite opposition from the congressional tree.
Justice Dias Toffoli, the fifth out of 11 courts to ballot for liberalization, emphasized that no person of any medicine should be considered a fugitive. If Brazil proceeds with liberalization, it would fit with the majority of its Spanish American companions.
A critical step remains: defining the hands control that differentiates private use from trafficking. This limit is anticipated to be established immediately, possibly as early as June 26. This decision is crucial for a nation with a remarkable prison population of 840, 000, which is the third-highest in the world after the U.S. and China, and has over 215 million residents. Brazil even has a large prison level, with 390 individuals per 100, 000 people.
Drug trafficking accounts for 28 % of Brazil’s prison population, according to Conectas, a human rights group. Although the National Congress’s laws from 2006 recommends a more permissive policy for those who use marijuana for personal use, such as for community service or educational purposes, it does not specify precise ownership restrictions. The country’s strict drug war has been perpetuated by this uncertainty.
Recent research reveals that knowledge levels vary depending on how marijuana possession is regulated. In So Paulo, people with post-graduate levels are usually deemed drug traffickers if found with more than 49 kilos of cannabis, according to a study conducted by the Portuguese Jurimetrics Association and cited by The Portuguese Report in May 2024.
Under the 2006 laws, judges assess private consumption by considering the amount and nature of the substance, the perspective of the arrest, and the animal’s social and personal circumstances. Despite the Supreme Court’s lot supporting liberalization, the choice faces possible parliamentary opposition. A Senate-passed legal act was prosecute any number of an illicit substance, challenging the Supreme Court’s ruling.
Rodrigo Pacheco, the president of the Senate, criticized the Supreme Court’s ruling, arguing that parliamentary programs should be used to handle these matters. If Congress move the act, the Supreme Court has the authority to act it illegal, setting up a possible fight between Brazil’s judicial and legislative branches over cannabis policy.
